Abstract 2651: Combination of an anti-angiogenic antibody with PD1/PDL1 blockade agents produces synergistic anti-tumor efficacy in preclinical models
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI